What does APOTHEEK VAN OVERLOOP do?

APOTHEEK VAN OVERLOOP is a pharmacy in Sint-Niklaas. Private Limited, started on 1 January 1972, 1 establishment.

What is the address of APOTHEEK VAN OVERLOOP?

The registered office of APOTHEEK VAN OVERLOOP is located at Plezantstraat 20, 9100 Sint-Niklaas.

Is APOTHEEK VAN OVERLOOP still active?

Yes. According to the CBE (31 October 2026) APOTHEEK VAN OVERLOOP is active, legal situation “Normale toestand”, started on 1 January 1972.

Is APOTHEEK VAN OVERLOOP registered on Peppol?

Yes, APOTHEEK VAN OVERLOOP is registered on the Peppol network with ID 0208:0412571583.

What is the enterprise number of APOTHEEK VAN OVERLOOP?

The enterprise number of APOTHEEK VAN OVERLOOP is BE0412571583.

When was APOTHEEK VAN OVERLOOP founded?

APOTHEEK VAN OVERLOOP was founded on 1 January 1972.

Who are the directors of APOTHEEK VAN OVERLOOP?

According to the 2025 annual accounts, the directors of APOTHEEK VAN OVERLOOP are: Elsie Van Overloop, Nicolas Van den Borre.

Is APOTHEEK VAN OVERLOOP a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 January 1972; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did APOTHEEK VAN OVERLOOP make in 2025?

APOTHEEK VAN OVERLOOP posted a profit after taxes of € 67,378 in financial year 2025.

What is the revenue of APOTHEEK VAN OVERLOOP?

As a small company, APOTHEEK VAN OVERLOOP is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 214,330.

How much does an employee at APOTHEEK VAN OVERLOOP earn?

The average wage cost per full-time employee at APOTHEEK VAN OVERLOOP was € 65,000 in 2025: staff costs of € 71,503 for 1.1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK VAN OVERLOOP have?

According to the 2025 annual accounts, APOTHEEK VAN OVERLOOP has 1.1 full-time equivalents (FTE).

APOTHEEK VAN OVERLOOP (Private Limited) - Sint-Niklaas

Dossier APOTHEEK VAN OVERLOOP, printed on 31 October 2026 from databakkes.be/en/0412571583/apotheek-van-overloop. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK VAN OVERLOOP from Sint-Niklaas, company number BE0412571583, closed financial year 2025 with a result of € 67,378 after tax. For that financial year APOTHEEK VAN OVERLOOP recorded a gross margin of € 214,330 and equity of € 282,034. Compared with financial year 2024, the result moved from € 16,427 to € 67,378. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 18, 2026.

What it is worth Growing

€ 282,034

▲ 31% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 67,378

▲ € 50,951 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 56,779

▲ 127% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 240,534.

People and assets in 2025

Full-time equivalents

1.1

▲ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 71,503

▲ 4% vs 2024

€ 65,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 111,345

▼ 56% vs 2024

€ 12,052 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 65,463

▲ 9% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 52,611

▲ 46% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 95,598 Gross margin 2022: € 95,598 First fiscal year in the series	€ 126,198 Gross margin 2023: € 126,198 ▲ 32% vs 2022 (€ 95,598) Favourable step	€ 143,665 Gross margin 2024: € 143,665 ▲ 14% vs 2023 (€ 126,198) Favourable step	€ 214,330 Gross margin 2025: € 214,330 ▲ 49% vs 2024 (€ 143,665) Favourable step	▲ 49%
Profit after taxes	€ 8,380 Profit after taxes 2022: € 8,380 First fiscal year in the series	€ 592 Profit after taxes 2023: € 592 ▼ 93% vs 2022 (€ 8,380) Unfavourable step	€ 16,427 Profit after taxes 2024: € 16,427 ▲ € 15,835 vs 2023 (€ 592) Favourable step	€ 67,378 Profit after taxes 2025: € 67,378 ▲ € 50,951 vs 2024 (€ 16,427) Favourable step	▲ € 50,951
Equity	€ 197,636 Equity 2022: € 197,636 First fiscal year in the series	€ 198,228 Equity 2023: € 198,228 Unchanged (€ 197,636) Favourable step	€ 214,656 Equity 2024: € 214,656 ▲ 8% vs 2023 (€ 198,228) Favourable step	€ 282,034 Equity 2025: € 282,034 ▲ 31% vs 2024 (€ 214,656) Favourable step	▲ 31%
Total debts	€ 395,935 Total debts 2022: € 395,935 First fiscal year in the series	€ 360,428 Total debts 2023: € 360,428 ▼ 9% vs 2022 (€ 395,935) Favourable step	€ 348,140 Total debts 2024: € 348,140 ▼ 3% vs 2023 (€ 360,428) Favourable step	€ 237,192 Total debts 2025: € 237,192 ▼ 32% vs 2024 (€ 348,140) Favourable step	▼ 32%
Cash	€ 43,178 Cash 2022: € 43,178 First fiscal year in the series	€ 42,806 Cash 2023: € 42,806 ▼ 1% vs 2022 (€ 43,178) Unfavourable step	€ 25,012 Cash 2024: € 25,012 ▼ 42% vs 2023 (€ 42,806) Unfavourable step	€ 56,779 Cash 2025: € 56,779 ▲ 127% vs 2024 (€ 25,012) Favourable step	▲ 127%
Land & buildings	€ 296,597 Land & buildings 2022: € 296,597 First fiscal year in the series	€ 279,775 Land & buildings 2023: € 279,775 ▼ 6% vs 2022 (€ 296,597) Unchanged	€ 263,039 Land & buildings 2024: € 263,039 ▼ 6% vs 2023 (€ 279,775) Unchanged	€ 174,845 Land & buildings 2025: € 174,845 ▼ 34% vs 2024 (€ 263,039) Unchanged	▼ 34%
Retained profit	€ 156,136 Retained profit 2022: € 156,136 First fiscal year in the series	€ 156,728 Retained profit 2023: € 156,728 Unchanged (€ 156,136) Favourable step	€ 173,156 Retained profit 2024: € 173,156 ▲ 10% vs 2023 (€ 156,728) Favourable step	€ 240,534 Retained profit 2025: € 240,534 ▲ 39% vs 2024 (€ 173,156) Favourable step	▲ 39%
Bank debt	€ 315,722 Bank debt 2022: € 315,722 First fiscal year in the series	€ 284,470 Bank debt 2023: € 284,470 ▼ 10% vs 2022 (€ 315,722) Favourable step	€ 250,727 Bank debt 2024: € 250,727 ▼ 12% vs 2023 (€ 284,470) Favourable step	€ 111,345 Bank debt 2025: € 111,345 ▼ 56% vs 2024 (€ 250,727) Favourable step	▼ 56%
Balance sheet total	€ 629,412 Balance sheet total 2022: € 629,412 First fiscal year in the series	€ 594,498 Balance sheet total 2023: € 594,498 ▼ 6% vs 2022 (€ 629,412) Unchanged	€ 598,637 Balance sheet total 2024: € 598,637 ▲ 1% vs 2023 (€ 594,498) Unchanged	€ 555,067 Balance sheet total 2025: € 555,067 ▼ 7% vs 2024 (€ 598,637) Unchanged	▼ 7%
Employees (FTE)	0.7 Employees (FTE) 2022: 0.7 First fiscal year in the series	1.4 Employees (FTE) 2023: 1.4 ▲ 0.7 vs 2022 (0.7) Unchanged	1 Employees (FTE) 2024: 1 ▼ 0.4 vs 2023 (1.4) Unchanged	1.1 Employees (FTE) 2025: 1.1 ▲ 0.1 vs 2024 (1) Unchanged	▲ 0.1

Key figures of APOTHEEK VAN OVERLOOP, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK VAN OVERLOOP?

What happened at APOTHEEK VAN OVERLOOP in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 18, 2026 New annual accounts for financial year 2025: profit of € 67,378 (▲ € 50,951 vs 2024). filed late Source: NBB ↗
2023 Elsie Van Overloop became a director. NBB
2023 Nicolas Van den Borre became a director. NBB
Jul 1, 1972 New establishment in Sint-Niklaas. KBO
Jan 1, 1972 Start of the company according to the CBE. KBO

In short

From € 8,380 profit in 2022 to € 67,378 profit in 2025.

Paid € 39,122 in corporate taxes since 2022.

Best year ever: 2025, with € 67,378 profit.

On average € 194,800 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Elsie Van Overloop Nicolas Van den Borre

APOTHEEK VAN OVERLOOP

Behind APOTHEEK VAN OVERLOOP are Elsie Van Overloop and Nicolas Van den Borre.

Directors

According to the 2025 annual accounts

Elsie Van Overloop

Director

since 2023

Nicolas Van den Borre

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Plezantstraat 20

9100 Sint-Niklaas

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0412.571.583

VAT number

BE 0412.571.583

Registered office

Plezantstraat 20, 9100 Sint-Niklaas

Names & denominations

APOTHEEK VAN OVERLOOP

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

1 January 1972

Peppol

Active · Active since 30 Nov 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden

Vervaardiging van brillen

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK VAN OVERLOOP

Financials

What happened to APOTHEEK VAN OVERLOOP?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions